Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP96446.RAbhmfuCTRECiRmVrALsol001ditNZdsi8gydHb2f8DUQ130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96446.RAbhmfuCTRECiRmVrALsol001ditNZdsi8gydHb2f8DUQ130_provenance.
• NP96483.RASYlmDpWdoHqIqudqf1oJEt1cSrBaJFVAS4BVottuTAw130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96483.RASYlmDpWdoHqIqudqf1oJEt1cSrBaJFVAS4BVottuTAw130_provenance.
• NP96759.RATpiNu_XY1jB6WnEeKTXY4U0W7IGrKolo-Dw9f41wh2s130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96759.RATpiNu_XY1jB6WnEeKTXY4U0W7IGrKolo-Dw9f41wh2s130_provenance.
• NP96793.RAa4NCTZj_jKq1olLjSrrnDkzyuu6_YpCgoYnJWK2H74o130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96793.RAa4NCTZj_jKq1olLjSrrnDkzyuu6_YpCgoYnJWK2H74o130_provenance.
• NP96840.RASrbybFyk0TifULlpWcSSp9C2q-k8jNXVGglZHdopfcY130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96840.RASrbybFyk0TifULlpWcSSp9C2q-k8jNXVGglZHdopfcY130_provenance.
• NP422696.RAbuXltN7tjJP5pt6YWR4YOMdaF35Nzjb0TAdbtn1WfHg130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422696.RAbuXltN7tjJP5pt6YWR4YOMdaF35Nzjb0TAdbtn1WfHg130_provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP117112.RAmeJ4V6HrS9jER5JDQkzPRqBiYMjumAD-gabiOU6ESAU130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117112.RAmeJ4V6HrS9jER5JDQkzPRqBiYMjumAD-gabiOU6ESAU130_provenance.
• NP117187.RAhnLJUzZDBi-sMJVKEtdJ4LdKUQ5ERU_b3Tqz8ooyOZw130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117187.RAhnLJUzZDBi-sMJVKEtdJ4LdKUQ5ERU_b3Tqz8ooyOZw130_provenance.
• NP135224.RAVGI1H5zBIA_GiRgVVcTSmeunI71bHVmoVmKzu9c52x4130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135224.RAVGI1H5zBIA_GiRgVVcTSmeunI71bHVmoVmKzu9c52x4130_provenance.
• NP135228.RAceSq34cg9rnogkSnbCznac7J7LBZHiVdElep5fS5Vto130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135228.RAceSq34cg9rnogkSnbCznac7J7LBZHiVdElep5fS5Vto130_provenance.
• NP135230.RAZvYPhyOe-kzT-A5pIsZfjxPFkrxQHL0TVmQ7EcbLWoU130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135230.RAZvYPhyOe-kzT-A5pIsZfjxPFkrxQHL0TVmQ7EcbLWoU130_provenance.
• NP135233.RAa93ncuW8jGvAMnYn2UpBoeYrszvhCa1BSrxEkImQSrE130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135233.RAa93ncuW8jGvAMnYn2UpBoeYrszvhCa1BSrxEkImQSrE130_provenance.
• NP73776.RAoIRWK_Pekx6QEhLDFITceujc_bU6LkiNf42tTJraYKI130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73776.RAoIRWK_Pekx6QEhLDFITceujc_bU6LkiNf42tTJraYKI130_provenance.
• NP84779.RAn5DEJg8X99sEpCyG2VLhKt9HtL48vuTXqg3zHbOaqCo130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84779.RAn5DEJg8X99sEpCyG2VLhKt9HtL48vuTXqg3zHbOaqCo130_provenance.
• NP96943.RAkJ3WzK0c8lo4iBpmGxGeub94ZNHSK8NJULQGaNeOWPY130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96943.RAkJ3WzK0c8lo4iBpmGxGeub94ZNHSK8NJULQGaNeOWPY130_provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP96517.RABf4oHB8zlEwXL5n0E6IAEtbHSJcs8e2fRomsYxHza9w130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96517.RABf4oHB8zlEwXL5n0E6IAEtbHSJcs8e2fRomsYxHza9w130_provenance.
• NP135234.RAAsbv8GdAzDb3LMjeLwARg_rFxv123HsjgSnyHluTjus130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135234.RAAsbv8GdAzDb3LMjeLwARg_rFxv123HsjgSnyHluTjus130_provenance.
• NP135232.RApWZGXq3mFUmMokjqMYkvle_c6Q-H1sHd9uQyBJ7dEQM130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135232.RApWZGXq3mFUmMokjqMYkvle_c6Q-H1sHd9uQyBJ7dEQM130_provenance.
• NP135235.RAvxhe6DR3avRlcsy8s5ZFtYGW9GUaaKXFwzaUZQPG-lI130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135235.RAvxhe6DR3avRlcsy8s5ZFtYGW9GUaaKXFwzaUZQPG-lI130_provenance.
• NP96611.RA5vSH0YF5KXJTJ2vQRnGjVZJA9PIYIKF-t22LnBh0m0E130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96611.RA5vSH0YF5KXJTJ2vQRnGjVZJA9PIYIKF-t22LnBh0m0E130_provenance.
• NP706491.RAvuy-0kLOEv7tLxHs19TA5CH4nKVKwpViwc8wLB7iJVc130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706491.RAvuy-0kLOEv7tLxHs19TA5CH4nKVKwpViwc8wLB7iJVc130_provenance.
• NP96651.RAJKgYZTB_B1Dqxr25pTcPRHPe5t1Sjj0xpILbOxnfX7Q130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96651.RAJKgYZTB_B1Dqxr25pTcPRHPe5t1Sjj0xpILbOxnfX7Q130_provenance.
• NP524638.RA7xW7iAgmxT61k6pJhFwnncESOBhOKO7gCMv72ZsIhtI130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524638.RA7xW7iAgmxT61k6pJhFwnncESOBhOKO7gCMv72ZsIhtI130_provenance.
• NP135225.RAH-1DRUy5TTBLZyrHBynhUJMSRmjY7NklCGfs6ggJwZA130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135225.RAH-1DRUy5TTBLZyrHBynhUJMSRmjY7NklCGfs6ggJwZA130_provenance.
• NP135226.RA_NXfvO1K43wSF3shGk9dPwCcv2LDhTAtfd2qGYqrPOI130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135226.RA_NXfvO1K43wSF3shGk9dPwCcv2LDhTAtfd2qGYqrPOI130_provenance.
• NP135227.RA49g3WiCLXyLVnqRNPHeSPQFRXi7FW9ZmLF2oCe9ziv4130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135227.RA49g3WiCLXyLVnqRNPHeSPQFRXi7FW9ZmLF2oCe9ziv4130_provenance.
• NP135229.RA4JhV8uufNmpF9Ev4PCN-5s6i9fRgEE1BdXrIo39qJW8130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135229.RA4JhV8uufNmpF9Ev4PCN-5s6i9fRgEE1BdXrIo39qJW8130_provenance.
• NP135231.RA8PUtj9MduZ2FVHWpFJ01ox4YHJpOPvshsvTHGqRd2-c130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135231.RA8PUtj9MduZ2FVHWpFJ01ox4YHJpOPvshsvTHGqRd2-c130_provenance.
• NP135236.RA1P-pG3N3Y6Q-7EPpCyF40iKlI2UeOVUZtWH430CPj10130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135236.RA1P-pG3N3Y6Q-7EPpCyF40iKlI2UeOVUZtWH430CPj10130_provenance.
• NP135237.RA9mQexKIrZnrkxdDBWm7DuYW0wOP7V0ecrb6a8zd6rKc130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135237.RA9mQexKIrZnrkxdDBWm7DuYW0wOP7V0ecrb6a8zd6rKc130_provenance.
• NP706493.RAyiPngIju25nYQo4Ly6tpQHfdfw2LHfzAM3gnsopgDrk130_assertion description "[Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706493.RAyiPngIju25nYQo4Ly6tpQHfdfw2LHfzAM3gnsopgDrk130_provenance.